Corrigendum to: “Biomimetic bioactive multifunctional poly(citrate-siloxane)-based nanofibrous scaffolds enable efficient multidrug-resistant bacterial treatment/non-invasive tracking in vitro/in vivo” [Chem. Eng. J. 383 (2020) 123078]

Xi, Yang; Guo, Youguang; Wang, Min; Juan, Gloria; Liu, Yanle; Niu, Wen; Chen, I‐Ming; Xue, Yumeng; Winston, Dagogo Dorothy; Dai, Wentong; Liu, Bo; Chen, Lin

doi:10.1016/j.cej.2022.138304

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For instance, the addition of antimicrobial polypeptide, EPL, into PCS (GT-50%PCS-EPL) resulted in a new material with robust anti-infection ability against multi-drug resistant bacteria (MDRB) infection. [283] In the subcutaneous infection model, the number of bacteria colonies in the wound area significantly decreased in the GT-50%PCS-EPL group compared to the control groups. Similarly, the inclusion of EPL during the synthesis of PCE resulted in broad-spectrum antibacterial properties against S. aureus, E. coli, P. aeruginosa, and E. faecalis.…”

Section: Antimicrobial Propertiesmentioning

confidence: 89%

Citric Acid: A Nexus Between Cellular Mechanisms and Biomaterial Innovations

Xu,

Yan,

Gerhard

et al. 2024

Advanced Materials

View full text Add to dashboard Cite

Citrate‐based biodegradable polymers have emerged as a distinctive biomaterial platform with tremendous potential for diverse medical applications. By harnessing their versatile chemistry, these polymers exhibit a wide range of material and bioactive properties, enabling them to regulate cell metabolism and stem cell differentiation through energy metabolism, metabonegenesis, angiogenesis and immunomodulation. Moreover, the recent U.S. Food and Drug Administration (FDA) clearance of the biodegradable poly(octamethylene citrate) (POC)/hydroxyapatite‐based orthopedic fixation devices represent a translational research milestone for biomaterial science. POC joins a short list of biodegradable synthetic polymers that have ever been authorized by the FDA for use in humans. The clinical success of POC has sparked enthusiasm and accelerated the development of next‐generation citrate‐based biomaterials. This review presents a comprehensive, forward‐thinking discussion on the pivotal role of citrate chemistry and metabolism in various tissue regeneration and on the development of functional citrate‐based metabotissugenic biomaterials for regenerative engineering applications.This article is protected by copyright. All rights reserved

show abstract

Section: Antimicrobial Propertiesmentioning

confidence: 89%

Citric Acid: A Nexus Between Cellular Mechanisms and Biomaterial Innovations

Xu,

Yan,

Gerhard

et al. 2024

Advanced Materials

View full text Add to dashboard Cite

show abstract

“…Poly(octamethylene citrate) (POC) Tissue engineering [107,131,134,136,137,154,156] Poly(1,2-propanediol-sebacate-citrate) (PPSC) Tissue engineering [172] POC-citric acid-sebacic acid (p(OCS)) Tissue engineering [173][174] Poly(octamethylene maleate citrate) (POMC) Tissue engineering [175] Poly(octamethylene maleate (anhydride) citrate) (POMaC) Tissue engineering cardiovascular engineering [142,[176][177] Urethane-doped CBBs (CUPEs) Tissue engineering [138] POC-lentivirus Tissue engineering [178] Poly(1,2-propanediol-co-1,8-octanediol-co-citrate) (PPOC) Tissue engineering [179] Poly(diol 4-ketopimelateco-diol citrate) Tissue engineering [180] Poly (silicone-citrate) (PSC) Tissue engineering [181][182] POC-polyhedral oligomeric silsesquioxances (POSS) Tissue engineering [183] POC-co-Pluronic F127 (POFC) Tissue engineering [184][185][186] POC-PLLA Tissue engineering [187][188] Poly(octamethylene-co-L-cysteine citrate)-co-polylactide BPLP-PLLA Tissue engineering [189] Poly(caprolactone-diol-citrate) (PCC) Tissue engineering [190] Poly(polyethylene glycol citrate-co-N-isopropylacrylamide) (PPCN)…”

Section: Materials Application Refsmentioning

confidence: 99%

Enabling Proregenerative Medical Devices via Citrate‐Based Biomaterials: Transitioning from Inert to Regenerative Biomaterials

Wang,

Huddleston,

Yang

et al. 2023

Advanced Materials

View full text Add to dashboard Cite

Regenerative medicine aims to restore tissue and organ function without the use of prosthetics and permanent implants. However, achieving this goal has been elusive, and the field remains mostly an academic discipline with few products widely used in clinical practice. From a materials science perspective, barriers include the lack of proregenerative biomaterials, a complex regulatory process to demonstrate safety and efficacy, and user adoption challenges. Although biomaterials, particularly biodegradable polymers, can play a major role in regenerative medicine, their suboptimal mechanical and degradation properties often limit their use, and they do not support inherent biological processes that facilitate tissue regeneration. As of 2020, nine synthetic biodegradable polymers used in medical devices are cleared or approved for use in the United States of America. Despite the limitations in the design, production, and marketing of these devices, this small number of biodegradable polymers has dominated the resorbable medical device market for the past 50 years. This perspective will review the history and applications of biodegradable polymers used in medical devices, highlight the need and requirements for regenerative biomaterials, and discuss the path behind the recent successful introduction of citrate‐based biomaterials for manufacturing innovative medical products aimed at improving the outcome of musculoskeletal surgeries.

show abstract

Corrigendum to: “Biomimetic bioactive multifunctional poly(citrate-siloxane)-based nanofibrous scaffolds enable efficient multidrug-resistant bacterial treatment/non-invasive tracking in vitro/in vivo” [Chem. Eng. J. 383 (2020) 123078]

Cited by 2 publications

References 0 publications

Citric Acid: A Nexus Between Cellular Mechanisms and Biomaterial Innovations

Citric Acid: A Nexus Between Cellular Mechanisms and Biomaterial Innovations

Enabling Proregenerative Medical Devices via Citrate‐Based Biomaterials: Transitioning from Inert to Regenerative Biomaterials

Contact Info

Product

Resources

About